<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2469</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2025-33-6-1473-1478</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>The History of Pharmaceutical Law. Report II. The Evolution of Legal Space of Pharmaceutical Sphere in XX Century</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Volskaya</surname><given-names>E. A.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">N. A. Semashko National Research Institute of Public Health 105064 Moscow Russia</aff><pub-date date-type="epub" iso-8601-date="2025-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2025</year></pub-date><volume>33</volume><issue>6</issue><fpage>1473</fpage><lpage>1478</lpage><history><pub-date date-type="received" iso-8601-date="2025-12-19"><day>19</day><month>12</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 2025,</copyright-statement><copyright-year>2025</copyright-year></permissions><abstract>This report is the second part of article devoted to history of development of pharmaceutical law. The second stage of development of regulatory norms in the field of pharmaceutical circulation is described. In XX century in conditions of developing pharmaceutical industry and expanding medication market the center of creation of regulatory acts shifted from European countries to North America. The European lawmakers when developing normative base for sphere of circulation of medications took into account experience and approaches of legal regulation in the USA. In the European states and the USA by the end of XX century harmonized complexes of legal norms in sphere of circulation of medications formed on the basis of national special laws on medicinal remedies.</abstract><kwd-group xml:lang="en"><kwd>pharmaceutical law medicinal remedy law regulation harmonization historical development</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фармацевтическое право лекарственное средство закон регулирование гармонизация историческое развитие</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Вольская Е. А. Развитие регулирования в сфере обращения лекарственных средств в ЕС и США в 1992—2020 гг. Сообщение 1. Формирование нормативно-правовой базы фармацевтической деятельности в США. Проблемы социальной гигиены здравоохранения и истории медицины. 2023;31(6):1426—32.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kieser T. Apothekenrecht. Einführung und Grundlagen. Dtsch. Apotheker Verlag; 2025. 177 S.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Шерстнева Е. В. Проблема доступности лекарственной помощи для населения России в начале ХХ века. Ремедиум. 2016;(11):18—20.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Stelzner S. Der pharmazeutische Markt in Europa. Masterarbeit; 2009. 130 S.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Препьялов А. В. Шестаков В. Н. Фармацевтическое право. Учебник. М.; 2023. 272 с.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>The Pure Food and Drug Act. Режим доступа: https://www.visitthecapitol.gov/exhibitions/congress-and-progressive-era/pure-food-and-drug-act#:~:text</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Federal Food Drug and Cosmetic Act. XML. Режим доступа: https://www.govinfo.gov/content/pkg/COMPS-973/pdf/COMPS-973.pdf</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>About FDA. Режим доступа: https://www.fda.gov/about-fda</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Verordnung betreffend den Verkehr mit Arzneimitteln. Vom 22. Oktober 1901. Режим доступа: https://de.wikisource.org/wiki/Verordnung_betreffend_den_Verkehr_mit_Arzneimitteln._Vom_22._Oktober_1901#:~:text</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Taxacher G. Hundert Jahre Gesetzeslücke. Der lande Weg zum Arzneimittelgesetz in Deutschland. Режим доступа: https://web.archive.org/web/20110228151128/http:/www.wdr.de/themen/gesundheit/pharmazie/contergan/arzneimittelrecht.jhtml?rubrikenstyle=contergan#expand</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelbgesetz). Bundesgesetzblatt. 1961;33:533—46.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Contergan-Skandal: Eine Tragödie und ihre Geschichte. Режим доступа: https://www.contergan-skandal.de/der-contergan-skandal</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Council Directive of 26 January1965 on the approximation of provisions laid down by law regulation or administrative action relating to proprietary medicinal products (65/65/EEC). Режим доступа: eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:31965L0065</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Loi du 25 mars 1964 sur les medicaments. Режим доступа: https://sherloc.unodc.org/cld/uploads/res/document/bel/1964/loi_du_25_mars_1964_sur_les_medicaments_html/Belgium_Loi_sur_les_medicaments.pdf</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Medicines Act 1968. Режим доступа: https://www.legislation.gov.uk/ukpga/1968</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Council Directive 92/25/EEC of 31 March 1992 on the wholesale distribution of medicinal products for human use. Режим доступа: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX%3A31992L0025</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Council Directive 92/26/EEC of 31 March 1992 concerning the classification for the supply of medicinal products for human use. Режим доступа: https://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX%3A31992L0026</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Council Directive 92/27/EEC of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets. Режим доступа: https://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX%3A31992L0027</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Council Directive 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use. Режим доступа: https://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX%3A31992L0028</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>О лекарственных средствах: Федеральный закон от 22 июня 1998 г. №86-ФЗ. Собрание законодательства РФ. 1998;(26).</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Постановление Правительства РФ от 24 июня 1998 г. №650 «О федеральной целевой программе «Развитие медицинской промышленности в 1998—2000 годах и на период до 2005 года». Режим доступа: https://normativ.kontur.ru/document?moduleId=1&amp;amp;documentId=28516</mixed-citation></ref></ref-list></back></article>
